يعرض 1 - 10 نتائج من 26 نتيجة بحث عن '"Advanced"', وقت الاستعلام: 0.79s تنقيح النتائج
  1. 1
    تقرير
    Study to Evaluate Adverse Events, Change in Disease Activity, and How ABBV-706 Moves Through the Body When Intravenously (IV) Infused Alone or in Combination With IV Infused Budigalimab, Cisplatin, or Carboplatin in Adult Participants With Advanced Solid Tumors

    المصدر: A Phase 1 First-in-Human Study Evaluating Safety, Pharmacokinetics and Efficacy of ABBV-706 as Monotherapy and in Combination With Budigalimab (ABBV-181), Carboplatin, or Cisplatin in Adult Subjects With Advanced Solid Tumors

    الوصول الحر: https://clinicaltrials.gov/ct2/show/NCT05599984Test

    Other URLs: https://www.abbvieclinicaltrials.com/study/?id=M24-108Test

    View record in ClinicalTrials.gov

    أضف إلى المفضلة
  2. 2
    تقرير
    Study to Assess Adverse Events and Change in Disease Activity in Adult Participants With Advanced Solid Tumors Receiving Intravenous (IV) ABBV-400 as Monotherapy and in Combination With IV Bevacizumab

    المصدر: A Phase 1 First in Human Study Evaluating Safety, Pharmacokinetics and Efficacy of ABBV-400 as Monotherapy and in Combination With Bevacizumab in Adult Subjects With Advanced Solid Tumors

    الوصول الحر: https://clinicaltrials.gov/ct2/show/NCT05029882Test

    View record in ClinicalTrials.gov

    أضف إلى المفضلة
  3. 3
    تقرير
    Study of Intravenous (IV) ABBV-637 Alone or in Combination With IV Docetaxel/Osimertinib to Assess Adverse Events and Change in Disease Activity in Adult Participants With Relapsed/Refractory (R/R) Solid Tumors

    المصدر: A Phase 1 First In Human Study Evaluating Safety And Efficacy Of ABBV-637 As Either Monotherapy Or In Combination In Adult Subjects With Relapsed And Refractory Solid Tumors

    الوصول الحر: https://clinicaltrials.gov/ct2/show/NCT04721015Test

    View record in ClinicalTrials.gov

    أضف إلى المفضلة
  4. 4
    تقرير
    A Study to Determine the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of ABBV-368 Plus Tilsotolimod and Other Therapy Combinations in Participants With Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma

    المؤلفون: Idera Pharmaceuticals, Inc.

    المصدر: A Phase 1b, Multicenter, Open-Label Study to Determine the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of ABBV-368 Plus Tilsotolimod and Other Therapy Combinations in Subjects With Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma

    الوصول الحر: https://clinicaltrials.gov/ct2/show/NCT04196283Test

    View record in ClinicalTrials.gov

    أضف إلى المفضلة
  5. 5
    تقرير
    A Study to Determine the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of ABBV-927 With ABBV-368, Budigalimab (ABBV-181) and/or Chemotherapy in Participants With Locally Advanced or Metastatic Solid Tumors

    المصدر: A Phase 1, Multicenter, Open-Label Study to Determine the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of Combinations of ABBV-927 With ABBV-368, Budigalimab (ABBV-181) and/or Chemotherapy in Subjects With Locally Advanced or Metastatic Solid Tumors

    الوصول الحر: https://clinicaltrials.gov/ct2/show/NCT03893955Test

    View record in ClinicalTrials.gov

    أضف إلى المفضلة
  6. 6
    تقرير
    Study to Determine the Safety, Tolerability, Pharmacokinetics and Recommended Phase 2 Dose (RP2D) of Livmoniplimab (ABBV-151) as a Single Agent and in Combination With Budigalimab (ABBV-181) in Participants With Locally Advanced or Metastatic Solid Tumors

    المصدر: A Phase 1 First-in Human, Multi-Center, Open Label Dose-Escalation Study to Determine the Safety, Tolerability, Pharmacokinetics and RP2D of Livmoniplimab (ABBV-151) as a Single Agent and in Combination With Budigalimab (ABBV-181) in Subjects With Locally Advanced or Metastatic Solid Tumors

    الوصول الحر: https://clinicaltrials.gov/ct2/show/NCT03821935Test

    Other URLs: https://www.abbvieclinicaltrials.com/study/?id=M19-345Test

    View record in ClinicalTrials.gov

    أضف إلى المفضلة
  7. 7
    تقرير
    A Study With ABBV-155 Alone and in Combination With Taxane Therapy in Adults With Relapsed and/or Refractory Solid Tumors

    المصدر: A Phase 1 First-in-Human Study With ABBV-155 Alone and in Combination With Taxane Therapy in Adults With Relapsed and/or Refractory Solid Tumors

    الوصول الحر: https://clinicaltrials.gov/ct2/show/NCT03595059Test

    View record in ClinicalTrials.gov

    أضف إلى المفضلة
  8. 8
    تقرير
    A Study to Evaluate the Safety and Pharmacokinetics ABBV-399 in Japanese Participants With Solid Tumors

    المصدر: A Phase I Study to Evaluate the Safety and Pharmacokinetics of ABBV-399 in Japanese Subjects With Advanced Solid Tumors

    الوصول الحر: https://clinicaltrials.gov/ct2/show/NCT03311477Test

    View record in ClinicalTrials.gov

    أضف إلى المفضلة
  9. 9
    تقرير
    A Study Evaluating the Safety, Pharmacokinetics, and Anti-tumor Activity of ABBV-321 in Subjects With Advanced Solid Tumors Associated With Overexpression of the Epidermal Growth Factor Receptor (EGFR)

    المصدر: A Phase 1 Study Evaluating the Safety, Pharmacokinetics, and Anti-tumor Activity of ABBV-321 in Subjects With Advanced Solid Tumors Associated With Overexpression of the Epidermal Growth Factor Receptor (EGFR)

    الوصول الحر: https://clinicaltrials.gov/ct2/show/NCT03234712Test

    View record in ClinicalTrials.gov

    أضف إلى المفضلة
  10. 10
    تقرير
    A Study Evaluating the Safety, Pharmacokinetics and Anti-Tumor Activity of ABBV-176 in Subjects With Advanced Solid Tumors Likely to Express Prolactin Receptor (PRLR)

    المصدر: A Phase 1 Study Evaluating the Safety, Pharmacokinetics and Anti-Tumor Activity of ABBV-176 in Subjects With Advanced Solid Tumors Likely to Express Prolactin Receptor (PRLR)

    الوصول الحر: https://clinicaltrials.gov/ct2/show/NCT03145909Test

    View record in ClinicalTrials.gov

    أضف إلى المفضلة
أدوات البحث: أحصل على تغذية RSS — أرسل هذا البحث بالبريد الإلكتروني — حفظ البحث